Skip to main content

Table 7 Parasitic clearance

From: Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

Treatment duration

ASAQ1

(N = 310)

ASAQ2

(N = 315)

AL

(N = 311)

Total

(N = 936)

Day 0

    

   N

310 (100%)

315 (100%)

311 (100%)

936 (100%)

   Density

37781 ± 45652

41863 ± 49049

33958 ± 41474

37880 ± 45575

Day 1

    

   N

198 (64.7%)

194 (61.8%)

206 (66.5%)

598 (64.3%)

   Density

3297 ± 8403

3137 ± 14753

3764 ± 14809

3406 ± 13002

Day 2

    

   N

26 (8.6%)

24 (7.7%)

25 (8.1%)

75 (8.1%)

   Density

503 ± 787

914 ± 3230

1098 ± 2585

833 ± 2383

Day 3

    

   N

None

2 (0.6%)

4 (1.3%)

6 (0.7%)

   Density

-

154 ± 76

464 ± 296

361 ± 282

  1. Data are presented as the number of patients with parasites (N) and as the mean parasite density ± SD for the patients with parasitaemia.